bpc 157 clinical trials human evidence safety bpc-157 review regulatory status BPC‑157 — 10 mg BPC 157 in Australia: Benefits,
Description
Daily injection compliance matters: GHK-Cu requires daily subcutaneous injection, which is not the right fit for patients who only want to inject their GLP-1 once a week
29 October 2021
The trials tested oral, intravenous, and subcutaneous routes of administration at doses ranging from micrograms to 1 mg per day
Nutrition: Follow a nutrient-dense, calorie-appropriate diet with adequate protein to help preserve lean mass
